Evidence map›Paper›PMID 40421458›Full record

ArticleCase reports in oncology

Extensive Bone Marrow Involvement by

Dina Soliman, Firyal Ibrahim, Hasan Rizvi, Mahir Petkar, Zsolt Lengyel, Aliya Habib Sange, Awni Alshurafa, Ruba Yasin

Abstract readCase Reports
In one paragraph

Article in Case reports in oncology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Dina SolimanDepartment of Laboratory Medicine and Pathology, Hamad Medical Corporation, Doha, Qatar.
Firyal IbrahimDepartment of Laboratory Medicine and Pathology, Hamad Medical Corporation, Doha, Qatar.
Hasan RizviDepartment of Laboratory Medicine and Pathology, Hamad Medical Corporation, Doha, Qatar.
Mahir PetkarDepartment of Laboratory Medicine and Pathology, Hamad Medical Corporation, Doha, Qatar.
Zsolt LengyelDepartment of Radiology (Clinical Imaging), National Center for Cancer Care and Research (NCCCR) - Hamad Medical Corporation (HMC), Doha, Qatar.
Aliya Habib SangeDubai Medical College, Doha, Qatar.
Awni AlshurafaDepartment of Hematology and Medical Oncology, National Center for Cancer Care and Research, Hamad Medical Corporation, Doha, Qatar.
Ruba YasinDepartment of Hematology and Medical Oncology, National Center for Cancer Care and Research, Hamad Medical Corporation, Doha, Qatar.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Erdheim-Chester disease (ECD) is a recently recognized clonal hematopoietic neoplasm characterized by activating alterations in the MAPK pathway. It involves multi-organ accumulation of abnormal histiocytes, leading to nonspecific clinical manifestations due to inflammation and fibrosis caused by histiocytic infiltration. Case Presentation: We present a 45-year-old male with nonspecific clinical symptoms and progressive skin and abdominal lesions. Multiple tissue biopsies revealed fibrohistiocytic infiltration but provided an inconclusive diagnosis. Imaging studies showed extensive fibrosis in the perinephric regions on CT and sclerotic foci in long and pelvic bones on PET/CT. Bone marrow biopsy revealed abnormal histiocytes with multinucleated giant forms, prominent emperipolesis, active hemophagocytosis, and condensed hemosiderin deposition. Immunohistochemistry showed positive histiocytes for CD68, CD163, and partially for S-100. Molecular analysis confirmed the Conclusion: The case highlights the need to recognize that ECD diagnosis requires integrating histopathology with clinical and radiographic findings. It emphasizes the importance of awareness of mixed histiocytosis features and the role of detecting BRAF mutations, even through immunohistochemistry, in suspected histiocytic neoplasms. Extensive bone marrow involvement by ECD is rarely described. To our knowledge, there are no prior reports of bi-phenotypic (concurrent) ECD/RDD mixed histiocytosis affecting the bone marrow.

Indexed as

Bi-phenotypic Erdheim-Chester disease/Rosai-Dorfman diseaseEmperipolesisErdheim-Chester diseaseMixed histiocytic neoplasmsOverlapping histiocytosisRosai-Dorfman syndrome

Identifiers

PMID40421458
PMCPMC12105831

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.